Grape IgG
FGGAG - Overview: Ganglioside GD1a Antibody (IgG)
Ganglioside GD1a Antibody (IgG)
Gluten IgG
FHMTB - Overview: Hydrocodone and metabolites
Hydrocodone and metabolites
FFLRO - Overview: Flunitrazepam Confirmation, Serum
Flunitrazepam Confirmation, Serum
PROLX - Overview: Fluphenazine (Prolixin), Serum
Fluphenazine (Prolixin), Serum
FEPHD - Overview: Ephedrine, Serum
Ephedrine, Serum
FFURO - Overview: Furosemide (Lasix)
Furosemide (Lasix)
FEPI - Overview: Epidermophyton floccosum IgE
Epidermophyton floccosum IgE
FENC - Overview: Encainide (Enkaid), ODE and MODE
Encainide (Enkaid), ODE and MODE
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...